Literature DB >> 6954968

6-Mercaptopurine: apparent lack of relation between prescribed dose and biological effect in children with leukaemia.

S Herber, L Lennard, J S Lilleyman, J Maddocks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6954968      PMCID： PMC2011067          DOI： 10.1038/bjc.1982.175

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  6 in total

1.  The treatment of acute lymphoblastic leukaemia.

Authors:  J V Simone
Journal:  Br J Haematol       Date:  1980-05       Impact factor: 6.998

2.  Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia.

Authors:  P J Kearney; P A Light; A Preece; M G Mott
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

3.  Assay of thioinosinic acid, an active metabolite of azathioprine, in human lymphocytes.

Authors:  L Fletcher; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

4.  A reliable method for evaluating drug compliance in children with cancer.

Authors:  S D Smith; D Rosen; R C Trueworthy; J T Lowman
Journal:  Cancer       Date:  1979-01       Impact factor: 6.860

5.  Variation in 17 oxogenic steroid excretion following oral prednisolone in children with lymphoblastic leukaemia.

Authors:  J S Lilleyman; A J French; I P Young
Journal:  Oncology       Date:  1981       Impact factor: 2.935

6.  Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia?

Authors:  C R Pinkerton; S G Welshman; J F Glasgow; J M Bridges
Journal:  Lancet       Date:  1980-11-01       Impact factor: 79.321
  6 in total
  9 in total

Review 1.  Normalisation of anti-cancer drug dosage using body weight and surface area: is it worthwhile? A review of theoretical and practical considerations.

Authors:  J J Reilly; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

2.  Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia.

Authors:  L Lennard; C A Rees; J S Lilleyman; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

3.  Methotrexate in neutrophils in children with acute lymphoblastic leukemia.

Authors:  H Schrøder
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

4.  Medical Research Council leukaemia trial, UKALL VII. A report to the Council by the Working Party on Leukaemia in Childhood.

Authors: 
Journal:  Arch Dis Child       Date:  1985-11       Impact factor: 3.791

5.  Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia.

Authors:  L Lennard; B E Gibson; T Nicole; J S Lilleyman
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

6.  Disturbance of 6-mercaptopurine metabolism by cotrimoxazole in childhood lymphoblastic leukaemia.

Authors:  C A Rees; L Lennard; J S Lilleyman; J L Maddocks
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

7.  Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?

Authors:  L Lennard; H A Davies; J S Lilleyman
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

8.  The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia.

Authors:  L Lennard; J S Lilleyman; J L Maddocks
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640

9.  Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization.

Authors:  J S Lilleyman; L Lennard; C A Rees; G Morgan; J L Maddocks
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.